Functional and mechanistic characterization of Foxd3 during mouse peri-implantation transitions.
Functional and mechanistic characterization of Foxd3 during mouse peri-implantation transitions.
批准号:
315100269
负责人:
Dr. Alvaro Rada-Iglesias
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2020-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Following implantation, epiblast cells within the mouse embryo undergo a critical cell fate decision, becoming specified towards either the perishable soma or the immortal germline. The pre-implantation epiblast displays naïve pluripotency and can give rise to all embryonic lineages. Upon implantation, the epiblast transits to a primed state, characterized by the loss of naïve pluripotency and the incipient expression of somatic genes. A few post-implantation epiblast cells are able to revert somatic differentiation and undergo major reprogramming events leading to germline specification. Using mouse embryonic stem cells as an in vitro differentiation model, we recently uncovered Foxd3 as a novel regulator that promotes the transition from naïve to primed pluripotency and, subsequently, prevents the acquisition of germline identity. Mechanistically, Foxd3 acts as a transcriptional repressor that decommissions enhancers necessary for the expression of key naïve pluripotency and germline genes. However, the in vivo relevance and evolutionary conservation of Foxd3 function during peri-implantation development are currently unknown. Here we propose a number of experiments that should provide mechanistic and functional insights into the role of Foxd3 in the post-implantation primed epiblast. We hypothesize that Foxd3 can act as a major epiblast patterning regulator conferring anterior identity. Using both in vitro and in vivo models, we will test whether this novel Foxd3 function is evolutionary conserved. Furthermore, we have previously shown in vitro that the silencing of Foxd3 is a critical regulatory event during the specification of mouse primordial germ cells (PGCs). In the current proposal, we will determine if this silencing event is equally important for in vivo germline specification and whether it is also relevant in humans. Overall, our work should provide a deeper understanding of the molecular mechanisms orchestrating peri-implantation development, which could help improving the in vitro derivation of PGCs and gametes and potentially opening new possibilities for the treatment of infertility.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Mechanistic and functional characterization of poised enhancers during the induction of major anterior neural loci using in vitro and in vivo developmental models.
-
批准号:251811628
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Dr. Alvaro Rada-Iglesias
-
依托单位:
国内基金
海外基金
登录
查看更多内容
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
-
批准号:82371631
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:卢慕峻
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
TRIM25-PHGDH信号轴调控脓毒症肺上皮细胞铁死亡的机制研究
-
批准号:82372151
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:童尧
-
依托单位:
芍药苷靶向α-烯醇化酶治疗实验性自身免疫性脑脊髓炎的机制研究
-
批准号:82371809
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:聂红
-
依托单位:
脂滴聚集型小胶质细胞介导的髓鞘病变促进小鼠抑郁样行为及其机制研究
-
批准号:82371528
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李媛
-
依托单位:
基于AMPK/PGC-1α信号轴的工程化外泌体靶向调控BMSCs能量代谢重编程在老年机体骨修复中的作用及其机制研究
-
批准号:82370920
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:周名亮
-
依托单位:
星形胶质细胞介导的髓鞘吞噬参与慢性脑低灌注白质损伤的机制研究
-
批准号:82371307
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汤耀辉
-
依托单位: